| 2023 | | Patient preference and efficacy of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis in patients with autoimmune diseases | 서창희, 손희준 |
| 2021 | | Autoantibody to KRAS is a potential biomarker for Sjogren's syndrome | 강호철, 서창희, 손인옥 |
| 2020 | | 전신홍반루푸스 마우스 모델에서의 정맥 내 톨유사 수용체 억제 펩타이드의 치료효과 | 서창희, 이성민 |
| 2020 | | Role of vitamin D as an indicator of disease activity in systemic lupus erythematosus | 서창희, 양청인 |
| 2019 | | The discovery of TCP1 as an SLE specific biomarker using sera of patients with SLE | 서창희, 이상원 |
| 2019 | | Characterization of salivary proteins identified as potential biomarkers for systemic lupus erythematosus through proteomic analysis | 서창희, 정주양 |
| 2016 | | Association and functional studies of genetic polymorphisms of MFGE8 gene in systemic lupus erythematosus | 서창희, 우지민 |
| 2015 | | TLR4 endogenous ligand S100A8/A9 levels in adult-onset Still’s disease and their association with disease activity and clinical manifestations | 김현아, 서창희 |
| 2014 | | Identification of microRNA associated with systemic lupus erythematosus in Korean | 김봉식, 서창희 |
| 2012 | | Genetic association study of interleukin 6 receptor and liver X receptor in systemic lupus erythematosus | 서창희, 전자영 |
| 2010 | | 한국인 전신성 홍반성 루푸스에서 Fcγ 수용체 유전자들의 다형성 | 김건영, 서창희 |
| 2009 | | Significance of vitamin D in systemic lupus erythematosus in Koreans | 서창희, 성준모 |
| 2008 | | Genetic Polymorphisms of Interleukin-6 in Systemic Lupus Erythematosus | 서창희, 전자영 |
| 2008 | | Significance of leptin and ghrelin in systemic lupus erythematosus in Koreans | 서창희, 최길순 |
| 2007 | | Beta2-microglobulin and antichromatin antibodies can be a disease activity markers in Systemic Lupus Erythematosus in Koreans | 김현아, 서창희 |
| 2006 | | Polymorphism at the Promoter of C-reactive Protein is Associated with Systemic Lupus Erythematosus in Koreans. | 서창희, 천혜영 |
| 2003 | | Clinical Significance of Rheumatoid Factor in Rheumatoid Arthritis | 서창희, 신유섭 |
